Table 2.
Clinical characteristics of RA patients
| Characteristics | Values |
|---|---|
| Disease duration (mean ± SD years) | 7.4 ± 7.5 |
| Active diseasea | 66.2% |
| Tobacco use | 18.6% |
| Extraarticular manifestations | 36.1% |
| ESR, mm/hour | 37.6 |
| DMARD naïve | 8.2% |
| Medications | |
| Corticosteroids | 67.5% |
| Methotrexate | 67.9% |
| Hydroxychloroquine | 46.5% |
| Leflunomide | 8.2% |
| TNF inhibitors | 16.3% |
ESR, erythrocyte sedimentation rate; DMARD, disease-modifying anti-rheumatic drugs; DD, disease duration.
a
Active disease defined by FDA criteria [presence of three or more of the following: morning stiffness (>45 min), swollen joints (>3 min), tender joints (>6 min) and sedimentation rate (>20 mm)].